Dupilumab_Metastatic NSCLC

NCT05013450 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

33

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Non-small Cell Lung Cancer

Interventions

DRUG: Dupilumab
DRUG: PD-1/PD-L1 blockade
DRUG: Anakinra

Sponsor

Thomas Marron